Literature DB >> 15871986

Gene transfer to the rat kidney in vivo and ex vivo using an adenovirus vector: factors influencing transgene expression.

Jun Fujishiro1, Shin-ichi Takeda, Yuichi Takeno, Koichi Takeuchi, Yukiyo Ogata, Masafumi Takahashi, Yoji Hakamata, Takashi Kaneko, Takashi Murakami, Takashi Okada, Keiya Ozawa, Kohei Hashizume, Eiji Kobayashi.   

Abstract

BACKGROUND: The characteristics of adenovirus-mediated gene transfer into the kidney are not well examined. We studied the effects of contact time and temperature on adenovirus-mediated transgene expression in rat kidneys, using catheter-based in vivo gene transfer and a rat renal transplant model ex vivo.
METHODS: An adenovirus vector containing the luciferase (Ad-Luc) or beta-galactosidase (Ad-LacZ) gene was introduced in vivo into the kidney via a renal artery catheter. Various contact times and temperatures were evaluated. Ex vivo, the renal graft was injected with Ad-Luc through the renal artery, chilled for 60 min and then transplanted. Luciferase expression was evaluated periodically by a non-invasive bioimaging system or histology. Cells expressing the LacZ gene were identified by immunoelectron microscopy.
RESULTS: In in vivo gene transfer, successful transgene expression was achieved; however, its efficiency was independent of contact time or temperature. In ex vivo gene transfer, transgene expression in the renal graft peaked early and gradually decreased. Strong gene expression was observed in the recipients' livers. LacZ expression was detected in fibroblasts, parietal epithelial cells of Bowman's capsule, mesangial cells, podocytes and tubular cells.
CONCLUSIONS: This study generated new information about in vivo and ex vivo gene transfer into the kidney, which would be useful for renal gene therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15871986     DOI: 10.1093/ndt/gfh783

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  6 in total

1.  Gene therapy to the kidney using viral vectors.

Authors:  Talha Akbulut; Frank Park
Journal:  Paidiatrike       Date:  2008

Review 2.  Improving Molecular Therapy in the Kidney.

Authors:  Jeffrey D Rubin; Michael A Barry
Journal:  Mol Diagn Ther       Date:  2020-08       Impact factor: 4.074

3.  Simian adenovirus type 35 has a recombinant genome comprising human and simian adenovirus sequences, which predicts its potential emergence as a human respiratory pathogen.

Authors:  Shoaleh Dehghan; Jason Seto; Morris S Jones; David W Dyer; James Chodosh; Donald Seto
Journal:  Virology       Date:  2013-10-08       Impact factor: 3.616

4.  Computational analysis of four human adenovirus type 4 genomes reveals molecular evolution through two interspecies recombination events.

Authors:  Shoaleh Dehghan; Jason Seto; Elizabeth B Liu; Michael P Walsh; David W Dyer; James Chodosh; Donald Seto
Journal:  Virology       Date:  2013-06-10       Impact factor: 3.616

5.  Bone marrow-derived mesenchymal stem cells ameliorate hepatic ischemia reperfusion injury in a rat model.

Authors:  Hiroyuki Kanazawa; Yasuhiro Fujimoto; Takumi Teratani; Junji Iwasaki; Naoya Kasahara; Kouji Negishi; Tatsuaki Tsuruyama; Shinji Uemoto; Eiji Kobayashi
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

6.  An adenovirus vector incorporating carbohydrate binding domains utilizes glycans for gene transfer.

Authors:  Julius W Kim; Joel N Glasgow; Masaharu Nakayama; Ferhat Ak; Hideyo Ugai; David T Curiel
Journal:  PLoS One       Date:  2013-02-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.